Literature DB >> 8730328

Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.

D Orphanidou1, M Gaga, A Rasidakis, K Dimakou, M Toumbis, P Latsi, J Pandalos, J Christacopoulou, J Jordanoglou.   

Abstract

Tumour necrosis factor (TNF) and interleukin-1 (IL-1) are powerful mediators with a key role in inflammation. This study was undertaken to study the presence of TNF and IL-1 in tuberculous effusion where there is marked inflammation and where examination of the pleural fluid may give information about the local inflammatory reaction. Adenosine deaminase activity (ADA, a marker of TB pleurisy) was also tested. Tumour necrosis factor, IL-1 and ADA levels were measured in the pleural fluid and serum of 97 patients; 33 with tuberculous effusion, 33 with malignant effusion, and 31 patients with benign non-tuberculous effusion. Pleural fluid TNF and ADA levels were higher in tuberculous (TB) patients than in patients with benign disorders or cancer (P < 0.01). Serum TNF levels were also higher in TB patients than other benign (P < 0.01) or malignant (P < 0.05) effusions. There was a positive correlation between serum and pleural fluid values (r = 0.998-0.999, P < 0.001) although pleural fluid concentration was higher (P < 0.001), possibly suggesting local production in the pleural cavity. Pleural fluid IL-1 levels were not raised in any patient group but there was a positive correlation between TNF and IL-1. In addition, a positive correlation was found between TNF and ADA levels, probably indicating some common production mechanism. Furthermore, ADA sensitivity in the diagnosis of tuberculous effusion was augmented by the combined use of TNF and ADA. The use of both these markers may prove useful in the differential diagnosis of TBC pleurisy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730328     DOI: 10.1016/s0954-6111(96)90205-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Diagnostic accuracy of interleukin-33 for tuberculous pleural effusion: A systematic review and meta-analysis.

Authors:  Xin-Yu Shi; Feng-Shuang Yi; Xin Qiao; Xue-Bin Pei; Shu-Feng Dong
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

2.  Alkaline phosphatase: Distinguishing between tuberculous and nontuberculous pleural effusion.

Authors:  Ashish Anantrao Jadhav; Jayashree Suhas Bardapurkar; Anuradha Jain
Journal:  Lung India       Date:  2009-07

3.  Predictive Role of ADA in Bronchoalveolar Lavage Fluid in Making the Diagnosis of Pulmonary Tuberculosis.

Authors:  Fariba Binesh; Abolhassan Halvani
Journal:  Pulm Med       Date:  2013-12-24

4.  Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.

Authors:  Kuan-Yuan Chen; Po-Hao Feng; Chih-Cheng Chang; Tzu-Tao Chen; Hsiao-Chi Chuang; Chun-Nin Lee; Chien-Ling Su; Lian-Yu Lin; Kang-Yun Lee
Journal:  Int J Gen Med       Date:  2016-06-11

5.  Diagnostic accuracy of tumor necrosis factor-alpha assay for tuberculous pleurisy: A PRISMA-compliant meta-analysis.

Authors:  Min Li; Zhuang Luo; Wenye Zhu; Rana Sami Ullah Khan; Saeed Ummai Ummair; Shaoqing Shi
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Hif-1α-Induced Expression of Il-1β Protects against Mycobacterial Infection in Zebrafish.

Authors:  Nikolay V Ogryzko; Amy Lewis; Heather L Wilson; Annemarie H Meijer; Stephen A Renshaw; Philip M Elks
Journal:  J Immunol       Date:  2018-12-14       Impact factor: 5.422

7.  Association between elevated pleural interleukin-33 levels and tuberculous pleurisy.

Authors:  Koung-Sun Lee; Hak-Ryul Kim; Seongae Kwak; Keum-Ha Choi; Ji-Hyun Cho; Young-Jin Lee; Mi-Kyung Lee; Jea-Hoon Lee; Seok-Don Park; Do-Sim Park
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

8.  Histone deacetylase inhibitor impairs plasminogen activator inhibitor-1 expression via inhibiting TNF-α-activated MAPK/AP-1 signaling cascade.

Authors:  Wei-Lin Chen; Joen-Rong Sheu; Che-Jen Hsiao; Shih-Hsin Hsiao; Chi-Li Chung; George Hsiao
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.